A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals

Arun Kumar ¹ , Sandeep Kumar ¹ , Arun Nanda ¹ *

Cited by CrossRef: 44

1- Bernasconi D, Bordignon S, Rossi F, Priola E, Nervi C, Gobetto R, Voinovich D, Hasa D, Duong N, Nishiyama Y, Chierotti M. Selective Synthesis of a Salt and a Cocrystal of the Ethionamide–Salicylic Acid System. Crystal Growth & Design. 2020;20(2):906 [Crossref]

2- An H, Choi I, Kim I. Melting Diagrams of Adefovir Dipivoxil and Dicarboxylic Acids: An Approach to Assess Cocrystal Compositions. Crystals. 2019;9(2):70 [Crossref]

3- Nugrahani I, Fisandra F, Horikawa A, Uekusa H. New Sodium Mefenamate – Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study. Journal of Pharmaceutical Sciences. 2021;110(9):3246 [Crossref]

4- Stevens J. Colorful 4,4-Bipyridine–Squaric Acid Multicomponent Complexes with Varying Degrees of Proton Transfer: Exploring the Nature of New Form IV in the Salt Co-Crystal Continuum. Crystal Growth & Design. 2022;22(1):779 [Crossref]

5- Sharma P, Gomila R, Frontera A, Barcelo-Oliver M, Bhattacharyya M. Dicarboxylic Acid-Based Co-Crystals of Pyridine Derivatives Involving Structure Guiding Unconventional Synthons: Experimental and Theoretical Studies. Crystals. 2022;12(10):1442 [Crossref]

6- Liu W, Ma R, Liang F, Duan C, Zhang G, Chen Y, Hao C. New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization. Molecules. 2021;26(9):2414 [Crossref]

7- Wong S, Chen Y, Xuan B, Sun C, Chow S. Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges. CrystEngComm. 2021;23(40):7005 [Crossref]

8- Segalina A, Pavan B, Ferretti V, Spizzo F, Botti G, Bianchi A, Pastore M, Dalpiaz A. Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers. Crystal Growth & Design. 2022;22(5):3090 [Crossref]

9- Anand R, Kumar A, Nanda A. Pharmaceutical Co-Crystals - Design, Development and Applications. DDL. 2020;10(3):169 [Crossref]

10- Saikia B, Pathak D, Sarma B. Variable stoichiometry cocrystals: occurrence and significance. CrystEngComm. 2021;23(26):4583 [Crossref]

11- Kiyonga E, Kekani L, Chidziwa T, Kahwenga K, Bronkhorst E, Milne M, Poka M, Mokhele S, Demana P, Witika B. Nano- and Crystal Engineering Approaches in the Development of Therapeutic Agents for Neoplastic Diseases. Crystals. 2022;12(7):926 [Crossref]

12- Kenguva G, Giri L, Rout S, Acharya A, Dandela R. Exploration of different solid variants of the anticancer medication Panobinostat (PNB) with improved physicochemical attributes. Journal of Molecular Structure. 2023;1292:136086 [Crossref]

13- Bolla G, Sarma B, Nangia A. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs. Chem Rev. 2022;122(13):11514 [Crossref]

14- Rana M, Garai A, Nangia A. Cocrystals and Salts of Milrinone with Fluoro Coformers: Improving Drug Dissolution and Diffusion and Calculating Normalized Diffusion for Pharmaceutical Cocrystals. Crystal Growth & Design. 2023;23(9):6461 [Crossref]

15- Selivanova I, Terekhov R. Crystal engineering as a scientific basis for modification of physicochemical properties of bioflavonoids. Russ Chem Bull. 2019;68(12):2155 [Crossref]

16- Palanisamy V, Sanphui P, Jyothi V, Shastri N, Bolla G, Palanisamy K, Prakash M, Vangala V. Tuning Diffusion Permeability of an Anti-Retroviral Drug, Emtricitabine, via Multicomponent Crystallizations. Crystal Growth & Design. 2021;21(3):1548 [Crossref]

17- Nascimento A, Fernandes R, Charpentier M, ter Horst J, Caires F, Chorilli M. Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement. Particuology. 2021;58:227 [Crossref]

18- SARAF G, BURADE K, GONJARI I, HOSMANI A, PAWAR A. A REVIEW ON ADVANCES IN PHARMACEUTICAL CO-CRYSTAL PREPARATION ROUTES, INTELLECTUAL PROPERTY PERSPECTIVE AND REGULATORY ASPECTS. Int J Curr Pharm Sci. 2022;:4 [Crossref]

19- Singh M, Barua H, Jyothi V, Dhondale M, Nambiar A, Agrawal A, Kumar P, Shastri N, Kumar D. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics. 2023;15(4):1161 [Crossref]

20- Neelam U, Daveedu B, Ambabhai V, Siripragada M, kumar S, Balasubramanian S. Physicochemical aspects and comparative analysis of Voxelotor and its salt and cocrystal. Journal of Molecular Structure. 2023;1271:134024 [Crossref]

21- Garg U, Azim Y. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. RSC Med Chem. 2021;12(5):705 [Crossref]

22- Jagia M, Kale D, Bansal A, Patel S. Novel Co-crystals and Eutectics of Febuxostat: Characterization, Mechanism of Formation, and Improved Dissolution. AAPS PharmSciTech. 2021;23(1) [Crossref]

23- Ganesan T, Muthudoss P, Voguri R, Ghosal S, Ann E, Kwok J, Shahnawaz S, Omar M, Allada R, See H. A new Febuxostat-Telmisartan Drug-Drug Cocrystal for Gout-Hypertension Combination Therapy. Journal of Pharmaceutical Sciences. 2022;111(12):3318 [Crossref]

24- Braga D. Crystal engineering: from promise to delivery. Chem Commun. 2023;59(95):14052 [Crossref]

25- Harfouche L, Couvrat N, Sanselme M, Brandel C, Cartigny Y, Petit S, Coquerel G. Discovery of New Proxyphylline-Based Chiral Cocrystals: Solid State Landscape and Dehydration Mechanism. Crystal Growth & Design. 2020;20(6):3842 [Crossref]

26- Garbacz P, Paukszta D, Sikorski A, Wesolowski M. Structural Characterization of Co-Crystals of Chlordiazepoxide with p-Aminobenzoic Acid and Lorazepam with Nicotinamide by DSC, X-ray Diffraction, FTIR and Raman Spectroscopy. Pharmaceutics. 2020;12(7):648 [Crossref]

27- Feliciano I, Silva D, Piedade M, Bernardes C, Minas da Piedade M. First and Second Dissociation Enthalpies in Bi-Component Crystals Consisting of Maleic Acid and L-Phenylalanine. Molecules. 2021;26(18):5714 [Crossref]

28- Nugrahani I, Parwati R. Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development. Molecules. 2021;26(14):4185 [Crossref]

29- Kacso I, Rus L, Martin F, Miclaus M, Filip X, Dan M. Solid-state compatibility studies of Ketoconazole-Fumaric acid co-crystal with tablet excipients. J Therm Anal Calorim. 2021;143(5):3499 [Crossref]

30- Kumbhar P, Kolekar K, Khot C, Dabhole S, Salawi A, Sabei F, Mohite A, Kole K, Mhatre S, Jha N, Manjappa A, Singh S, Dua K, Disouza J, Patravale V. Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications. Journal of Controlled Release. 2023;353:1150 [Crossref]

31- Dračínský M. Analyzing Discrepancies in Chemical-Shift Predictions of Solid Pyridinium Fumarates. Molecules. 2021;26(13):3857 [Crossref]

32- De Silva V, Averkiev B, Sinha A, Aakeröy C. The Balance between Hydrogen Bonds, Halogen Bonds, and Chalcogen Bonds in the Crystal Structures of a Series of 1,3,4-Chalcogenadiazoles. Molecules. 2021;26(14):4125 [Crossref]

33- Batisai E. Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach. ChemistryOpen. 2021;10(12):1260 [Crossref]

34- Al-Kazemi R, Al-Basarah Y, Nada A. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization. Adv Pharm Bull. 2019;9(4):559 [Crossref]

35- Acebedo-Martínez F, Alarcón-Payer C, Rodríguez-Domingo L, Domínguez-Martín A, Gómez-Morales J, Choquesillo-Lazarte D. Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation. Crystals. 2021;11(11):1339 [Crossref]

36- Kumar A, Nanda A. In-silico methods of cocrystal screening: A review on tools for rational design of pharmaceutical cocrystals. Journal of Drug Delivery Science and Technology. 2021;63:102527 [Crossref]

37- Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect. 2022;7(37) [Crossref]

38- Xia M, Zhu B, Wang J, Yang Z, Mei X. Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues. ACS Med Chem Lett. 2022;13(1):29 [Crossref]

39- Hassanain H, Al-Sharif S, Al-Ghamdi H, Nahari L, Al-Sulami A, Mousally S, Al-Zaydi K. Synthesis, Crystal Structure, Hirshfeld Surface Analysis, Energy Framework Calculations, and Halogen Bonding Investigation of Benzene-1,3,5-triyltris((4-chlorophenyl)methanone). Crystals. 2023;14(1):17 [Crossref]

40- Verma P, Srivastava A, Tandon P, Shimpi M. Insights into structural, spectroscopic, and hydrogen bonding interaction patterns of nicotinamide–oxalic acid (form I) salt by using experimental and theoretical approaches. Front Chem. 2023;11 [Crossref]

41- Banerjee M, Nimkar K, Naik S, Patravale V. Unlocking the potential of drug-drug cocrystals – A comprehensive review. Journal of Controlled Release. 2022;348:456 [Crossref]

42- Long B, Verma V, Ryan K, Padrela L. Generation and physicochemical characterization of posaconazole cocrystals using Gas Antisolvent (GAS) and Supercritical Solvent (CSS) methods. The Journal of Supercritical Fluids. 2021;170:105134 [Crossref]

43- Hossain Mithu M, Economidou S, Trivedi V, Bhatt S, Douroumis D. Advanced Methodologies for Pharmaceutical Salt Synthesis. Crystal Growth & Design. 2021;21(2):1358 [Crossref]

44- Štoček J, Socha O, Císařová I, Slanina T, Dračínský M. Importance of Nuclear Quantum Effects for Molecular Cocrystals with Short Hydrogen Bonds. J Am Chem Soc. 2022;144(16):7111 [Crossref]

45- Zochedh A, Chandran K, Shunmuganarayanan A, Sultan A. Exploring the Synergistic Effect of Tegafur-Syringic Acid Adduct Against Breast Cancer through DFT Computation, Spectroscopy, Pharmacokinetics and Molecular Docking Simulation. Polycyclic Aromatic Compounds. 2023;:1 [Crossref]